Vospire ER is a medicine licensed to treat airway spasms caused by asthma or chronic obstructive pulmonary disease (COPD). Part of a class of drugs known as beta agonists, it works by relaxing the muscles around airways, which opens them up and allows more air to get into and through the lungs. The medication comes in tablet form and is generally taken twice daily.
Vospire ER® (albuterol tablets) is a prescription medication used to treat airway spasms (called bronchospasms) in adults and children as young as six years old. Bronchospasms are most common in people with asthma. However, they can also occur in people with chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. Vospire ER tablets are extended release, meaning they are slowly dissolved over time.
Vospire ER is made by DAVA Pharmaceuticals.
Normally, air moves easily into and out of the lungs through a network of airways. However, during an asthma attack, the muscles around these airways tighten. This narrows the airways and makes it harder to breathe. This is called bronchospasm.
Vospire ER is part of a class of drugs called beta-adrenergic receptor agonists, or beta agonists for short. Beta agonists stimulate beta receptors in the body, including those on the muscles around airways. This stimulation causes the muscles to relax, which opens up the airways and allows more air to get into and through the lungs.
Vospire ER also has some effects on decreasing the activity of mast cells in the lungs, which play an important role in inflammation and allergic reactions.